Luo X, et al. - Experts conducted a meta-analysis to evaluate the risk of malignancy in psoriatic arthritis (PsA) patients undergoing therapy. During therapy, the estimation of cancer risk in PsA patients was allowed in this study. Findings suggested that therapy had a significant positive association with increased risk for overall malignancy relative to the general population as the reference group. An increased risk for non-melanoma skin cancers was seen specifically in patients with PsA undergoing treatment vs controls.